| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Ray Debanjan is a Chief Financial Officer at CTMX. Recent filings cover 0 purchases and 21 sales. Those positions are worth an estimated $20K at current prices.
Ray Debanjan's largest disclosed position is in CTMX as Chief Financial Officer, worth about $20K. The recent filings there lean toward selling, a net 80,048 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2018 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sell | 2,548 | $26.69 | $68,009.94 | -35.0% | |
| Jan 2, 2018 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sell | 2,500 | $21.11 | $52,775.00 | -25.5% | |
| Dec 1, 2017 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sell | 2,500 | $20.58 | $51,450.00 | -20.3% | |
| Nov 1, 2017 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sell | 2,500 | $20.00 | $50,000.00 | -17.1% | |
| Oct 2, 2017 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sell | 2,500 | $18.10 | $45,250.00 | -14.6% | |
| Sep 1, 2017 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sell | 2,500 | $17.17 | $42,925.00 | -12.7% | |
| Aug 9, 2017 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sell | 2,500 | $15.00 | $37,500.00 | -11.3% | |
| Jul 3, 2017 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sell | 2,500 | $15.47 | $38,675.00 | -10.2% |